Human Papilloma Virus Vaccine Introduction (HPVVI Phase 1)
Cervical cancer, primarily caused by persistent infection with high-risk strains of the Human Papillomavirus (HPV), represents a significant public health burden in Nigeria. As a leading cause of cancer-related deaths among women, the introduction of the HPV vaccine is critical in reducing the incidence and mortality of cervical cancer. The HPV Vaccine Introduction (HPVVI) project, […]